Samuel R Saks Insider Trading $PDLI PDL BIOPHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Samuel R Saks.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Samuel R Saks. Samuel R Saks is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in DEPOMED INC ($DMI) and Chief Development Officer in Protagonist Therapeutics, Inc ($PTGX) and Chief Medical Officer in Protagonist Therapeutics, Inc ($PTGX) and Director in Tonix Pharmaceuticals Holding Corp. ($TNXP) and Chief Development Officer in Auspex Pharmaceuticals, Inc. ($ASPX).
Samuel R Saks in PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Samuel R Saks: Director
Holdings: 214,190 shares
Current Value: $473,360
Latest Transaction: Jun 24 2019
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Samuel R Saks in PDL BIOPHARMA, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DMI, ASPX, PDLI, PTGX, TNXP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | Saks Samuel R | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
| Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | Saks Samuel R | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
| Jun 12 2018 | PDLI | PDL BIOPHARMA, INC ... | Saks Samuel R | Director | Grant | A | 2.76 | 54,348 | 150,000 | 214,190 | 159.8 K to 214.2 K (+34.00 %) |
| Jun 12 2017 | PDLI | PDL BIOPHARMA, INC ... | Saks Samuel R | Director | Grant | A | 2.47 | 60,729 | 150,001 | 159,842 | 99.1 K to 159.8 K (+61.27 %) |
| Jun 03 2016 | PDLI | PDL BIOPHARMA, INC ... | Saks Samuel R | Director | Grant | A | 3.52 | 71,023 | 250,001 | 99,113 | 28.1 K to 99.1 K (+252.84 %) |
| Sep 16 2015 | PDLI | PDL BIOPHARMA, INC ... | Saks Samuel R | Director | Grant | A | 5.34 | 28,090 | 150,001 | 28,090 | 0 to 28.1 K |
Page: 1